191 related articles for article (PubMed ID: 27881473)
1. Clinicopathological features of neoplasms with neuroendocrine differentiation occurring in the liver.
Nomura Y; Nakashima O; Akiba J; Ogasawara S; Fukutomi S; Yamaguchi R; Kusano H; Kage M; Okuda K; Yano H
J Clin Pathol; 2017 Jul; 70(7):563-570. PubMed ID: 27881473
[TBL] [Abstract][Full Text] [Related]
2. Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature.
Choi GH; Ann SY; Lee SI; Kim SB; Song IH
World J Gastroenterol; 2016 Nov; 22(41):9229-9234. PubMed ID: 27895410
[TBL] [Abstract][Full Text] [Related]
3. Histological features of mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver: a case report and literature review.
Nishino H; Hatano E; Seo S; Shibuya S; Anazawa T; Iida T; Masui T; Taura K; Haga H; Uemoto S
Clin J Gastroenterol; 2016 Aug; 9(4):272-9. PubMed ID: 27384317
[TBL] [Abstract][Full Text] [Related]
4. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
5. Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule.
Kano Y; Kakinuma S; Goto F; Azuma S; Nishimura-Sakurai Y; Itsui Y; Nakagawa M; Kudo A; Tanabe M; Kirimura S; Amano T; Ito T; Akashi T; Asahina Y; Watanabe M
Clin J Gastroenterol; 2014 Oct; 7(5):449-54. PubMed ID: 26184027
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic features of combined hepatic carcinoma].
He C; Yin HF; Liu P; Zhang Y; Zhang JB
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):824-8. PubMed ID: 24507101
[TBL] [Abstract][Full Text] [Related]
8. Primary hepatic neoplasms arising in cirrhotic livers can have a variable spectrum of neuroendocrine differentiation.
Shi C; Jug R; Bean SM; Jeck WR; Guy CD
Hum Pathol; 2021 Oct; 116():63-72. PubMed ID: 34310982
[TBL] [Abstract][Full Text] [Related]
9. Combined primary neuroendocrine carcinoma and hepatocellular carcinoma of the liver.
Yang CS; Wen MC; Jan YJ; Wang J; Wu CC
J Chin Med Assoc; 2009 Aug; 72(8):430-3. PubMed ID: 19686999
[TBL] [Abstract][Full Text] [Related]
10. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.
Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V
Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320
[TBL] [Abstract][Full Text] [Related]
11. [Study on clinicopathologic grading system and prognosis of primary hepatic neuroendocrine neoplasms].
Zhao J; Yang B; Xu C; Zhang WS; Ji Y; Chen LL; Tan YS; Zeng HY; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):102-6. PubMed ID: 22455886
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
[TBL] [Abstract][Full Text] [Related]
13. A fat containing combined neuroendocrine carcinoma and hepatocellular carcinoma in the liver: A case report.
Ikeda A; Aoki K; Terashima T; Itokawa Y; Kokuryu H
Ann Hepatol; 2021; 22():100183. PubMed ID: 32111487
[TBL] [Abstract][Full Text] [Related]
14. Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.
Tang LH; Untch BR; Reidy DL; O'Reilly E; Dhall D; Jih L; Basturk O; Allen PJ; Klimstra DS
Clin Cancer Res; 2016 Feb; 22(4):1011-7. PubMed ID: 26482044
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract][Full Text] [Related]
16. Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments.
Korse CM; Taal BG; Vincent A; van Velthuysen ML; Baas P; Buning-Kager JC; Linders TC; Bonfrer JM
Eur J Cancer; 2012 Mar; 48(5):662-71. PubMed ID: 21945100
[TBL] [Abstract][Full Text] [Related]
17. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Auernhammer CJ; Jauch KW; Hoffmann JN
Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
[TBL] [Abstract][Full Text] [Related]
18. Combined primary hepatic neuroendocrine carcinoma and hepatocellular carcinoma: case report and literature review.
Nakano A; Hirabayashi K; Yamamuro H; Mashiko T; Masuoka Y; Yamamoto S; Ozawa S; Nakagohri T
World J Surg Oncol; 2021 Mar; 19(1):78. PubMed ID: 33726764
[TBL] [Abstract][Full Text] [Related]
19. Clinical analysis of gastroenteropancreatic neuroendocrine tumor with liver metastasis, compared with primary hepatic neuroendocrine tumor.
Shen YH; Chen S; Zhang WT; Ji Y; Yu L; Sun HC; Qiu SJ; Ren N; Zhou J
J Cancer Res Ther; 2014 Dec; 10 Suppl():276-80. PubMed ID: 25693935
[TBL] [Abstract][Full Text] [Related]
20. The poor prognosis factors in G2 neuroendocrine tumor.
Poiană C; Neamţu MC; Avramescu ET; Carşote M; Trifănescu R; Terzea D; Neamţu OM; Ferechide D; Dănciulescu Miulescu R
Rom J Morphol Embryol; 2013; 54(3 Suppl):717-20. PubMed ID: 24322017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
